Ab170483

antibody from Aladdin Scientific Corporation

Targeting: KLRC1 CD159a, NKG2, NKG2-A, NKG2-B

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Functional assay (Data presented on provider website)

Antibody Data

Product number

Ab170483

Provider

Aladdin Scientific Corporation

Product name

Monalizumab (anti-NKG2A)

Antibody type

Recombinant

Description

Monalizumab is a first-in-class immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC).Purity >95% (SDS-PAGE&SEC)Endotoxin Level < 1.0EU/mg

Reactivity

Human

Conjugate

Unconjugated

Vial size

10mg,1mg,5mg

Concentration

Lot by Lot

Storage

Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.